{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:30:28Z","timestamp":1767918628977,"version":"3.49.0"},"reference-count":39,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T00:00:00Z","timestamp":1618444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Fatty liver is one of the most common metabolic syndrome affecting the global population. Presently, limited treatment modalities with symptomatic approach are available for alleviating fatty liver. Traditional and herbal treatment modalities have shown evidence to improve the disease pathology. In the present research work, evaluation of a selected medicinal plant <jats:italic>Lysimachia candida<\/jats:italic> Lindl. was carried out to investigate its beneficial effects on fatty liver disease in rats. Male Sprague Dawley (SD) rats were fed with high-fat high-fructose diet to induce fatty liver phenotypes. After induction for 15\u00a0weeks, methanolic extract of <jats:italic>Lysimachia candida<\/jats:italic> Lindl. (250\u00a0mg\/kg b. w. p. o.) was administrated to the rats daily for the next 17\u00a0weeks. Blood samples were collected at different time points to analyze fasting blood glucose levels and relevant biochemical parameters important for the assessment of metabolic disease phenotypes. Liquid chromatography-mass spectrometry (LC-MS) based metabolomics was done to study the dynamics of metabolic changes in the serum during disease progression and how the medicinally important plant extract treatment reversed the metabolic diseases. Multivariate data analysis approaches have been employed to understand the metabolome changes and disease pathology. This study has identified the interplay of some metabolic pathways that alter the disease progression and their reversal after administration of the plant extract. Different group of metabolites mainly bile acids, fatty acids, carnitines, and their derivatives were found to be altered in the diseased rats. However, all the metabolites identified between control and disease groups are mainly related to lipid metabolism. The results depict that the treatment with the above-mentioned plant extract improves the regulation of aberrant lipid metabolism, and reverses the metabolic syndrome phenotype. Therefore, the present study reveals the potential mechanism of the herbal extract to prevent metabolic syndrome in rats.<\/jats:p>","DOI":"10.3389\/fphar.2021.653872","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T20:19:13Z","timestamp":1618517953000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Methanolic Extract of Lysimachia Candida Lindl. Prevents High-Fat High-Fructose-Induced Fatty Liver in Rats: Understanding the Molecular Mechanism Through Untargeted Metabolomics Study"],"prefix":"10.3389","volume":"12","author":[{"given":"Parul","family":"Kamboj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumalya","family":"Sarkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonu Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neema","family":"Bisht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepika","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Md. Jahangir","family":"Alam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sagar","family":"Barge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhaswati","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barsha","family":"Deka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simanta","family":"Bharadwaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seydur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Partha Pratim","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jagat C.","family":"Borah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narayan Chandra","family":"Talukdar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay K.","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yashwant","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"609","DOI":"10.12968\/hosp.2004.65.10.16611","article-title":"Fatty liver","volume":"65","author":"Allison","year":"2004","journal-title":"Hosp. Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/s1665-2681(19)31922-2","article-title":"Prevalence of non-alcoholic fatty liver disease: population based study","volume":"6","author":"Amarapurkar","year":"2007","journal-title":"Ann. Hepatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/hep.20734","article-title":"Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study","volume":"42","author":"Bedogni","year":"2005","journal-title":"Hepatology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.jhep.2013.05.030","article-title":"The metabolomic window into hepatobiliary disease","volume":"59","author":"Beyo\u011flu","year":"2013","journal-title":"J. Hepatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1093\/jn\/138.9.1677","article-title":"The major green tea polyphenol, (-)-Epigallocatechin-3-Gallate, inhibits obesity, metabolic syndrome, and fatty liver disease in high-fat-fed mice","volume":"138","author":"Bose","year":"2008","journal-title":"J. Nutr."},{"key":"B6","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.gtc.2016.07.003","article-title":"Nonalcoholic fatty liver disease","volume":"45","author":"Carr","year":"2016","journal-title":"Gastroenterol. Clin. North America"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.1093\/jn\/131.12.3166","article-title":"Oxidized frying Oil up-regulates hepatic acyl-CoA oxidase and cytochrome P450 4 A1 genes in rats and activates PPAR\u03b1","volume":"131","author":"Chao","year":"2001","journal-title":"J. Nutr."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2713","DOI":"10.1002\/jcb.27635","article-title":"Interaction of gut microbiota with dysregulation of bile acids in the pathogenesis of nonalcoholic fatty liver disease and potential therapeutic implications of probiotics","volume":"120","author":"Chen","year":"2019","journal-title":"J. Cel. Biochem."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1016\/j.fct.2010.04.044","article-title":"Cissus quadrangularis stem alleviates insulin resistance, oxidative injury and fatty liver disease in rats fed high fat plus fructose diet","volume":"48","author":"Chidambaram","year":"2010","journal-title":"Food Chem. Toxicol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"4312","DOI":"10.1073\/pnas.94.9.4312","article-title":"Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors and","volume":"94","author":"Forman","year":"1997","journal-title":"Proc. Natl. Acad. Sci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrendo.2017.42","article-title":"Endocrine-disrupting chemicals and fatty liver disease","volume":"13","author":"Foulds","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00611","article-title":"Gut dysfunction and non-alcoholic fatty liver disease","volume":"10","author":"Grabherr","year":"2019","journal-title":"Front. Endocrinol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1211\/jpp.57.10.0013","article-title":"Protective effects of theAlisma orientalisextract on the experimental nonalcoholic fatty liver disease","volume":"58","author":"Hong","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.3390\/molecules20022425","article-title":"A review of odd-chain fatty acid metabolism and the role of pentadecanoic Acid (c15:0) and heptadecanoic Acid (c17:0) in health and disease","volume":"20","author":"Jenkins","year":"2015","journal-title":"Molecules"},{"key":"B15","doi-asserted-by":"publisher","first-page":"11824","DOI":"10.1038\/s41598-020-68796-4","article-title":"Metabolomic analysis of primary human skeletal muscle cells during myogenic progression","volume":"10","author":"Kumar","year":"2020","journal-title":"Sci. Rep."},{"key":"B16","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1128\/mcb.15.6.3012","article-title":"Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators","volume":"15","author":"Lee","year":"1995","journal-title":"Mol. Cel. Biol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"530","DOI":"10.4254\/wjh.v10.i8.530","article-title":"Current status of imaging in nonalcoholic fatty liver disease","volume":"10","author":"Li","year":"2018","journal-title":"World J. Hepatol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fphar.2020.00012","article-title":"Naturally occurring TPE-CA maintains gut microbiota and bile acids homeostasis via FXR signaling modulation of the liver-gut Axis","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00018-003-3216-3","article-title":"Peroxisome proliferator-activated receptor a target genes","volume":"61","author":"Mandard","year":"2004","journal-title":"Cell Mol. Life Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic fatty liver disease: a feature of the metabolic syndrome","volume":"50","author":"Marchesini","year":"2001","journal-title":"Diabetes"},{"key":"B21","doi-asserted-by":"publisher","first-page":"7933","DOI":"10.1021\/acs.analchem.7b00925","article-title":"Development of a liquid chromatography-high resolution mass spectrometry metabolomics method with high specificity for metabolite identification using all ion fragmentation acquisition","volume":"89","author":"Naz","year":"2017","journal-title":"Anal. Chem."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e1900109","DOI":"10.1002\/mnfr.201900109","article-title":"Vitamin D deficiency in rats causes cardiac dysfunction by inducing myocardial insulin resistance","volume":"63","author":"Nizami","year":"2019","journal-title":"Mol. Nutr. Food Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1007\/bf02974078","article-title":"Acanthopanax senticosus reverses fatty liver disease and hyperglycemia in ob\/ob mice","volume":"29","author":"Park","year":"2006","journal-title":"Arch. Pharm. Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1136\/gutjnl-2015-310283","article-title":"Microbiota-induced obesity requires farnesoid X receptor","volume":"66","author":"Pars\u00e9us","year":"2017","journal-title":"Gut"},{"key":"B25","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1210\/me.2002-0120","article-title":"Bile acids induce the expression of the human peroxisome proliferator-activated receptor \u03b1 gene via activation of the farnesoid X receptor","volume":"17","author":"Pineda Torra","year":"2003","journal-title":"Mol. Endocrinol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1002\/hep.23229","article-title":"The plasma lipidomic signature of nonalcoholic steatohepatitis","volume":"50","author":"Puri","year":"2009","journal-title":"Hepatology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"08002","DOI":"10.1621\/nrs.08002","article-title":"PPAR\u03b1: energy combustion, hypolipidemia, inflammation and cancer","volume":"8","author":"Pyper","year":"2010","journal-title":"Nucl. Recept Signal."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1001\/jama.2015.5370","article-title":"Nonalcoholic fatty liver disease","volume":"313","author":"Rinella","year":"2015","journal-title":"JAMA"},{"key":"B29","doi-asserted-by":"publisher","first-page":"118404","DOI":"10.1016\/j.lfs.2020.118404","article-title":"Hypoxia aggravates non-alcoholic fatty liver disease in presence of high fat choline deficient diet: a pilot study","volume":"260","author":"Sarkar","year":"2020","journal-title":"Life Sci."},{"key":"B30","doi-asserted-by":"publisher","first-page":"6549","DOI":"10.3748\/wjg.v23.i36.6549","article-title":"Treatment options for alcoholic and non-alcoholic fatty liver disease: A review","volume":"23","author":"Singh","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1038\/s41591-018-0222-4","article-title":"Gut microbiota and intestinal FXR mediate the clinical benefits of metformin","volume":"24","author":"Sun","year":"2018","journal-title":"Nat. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"14634","DOI":"10.3390\/ijms131114634","article-title":"Radix paeoniae rubra and radix paeoniae alba attenuate CCl4-induced acute liver injury: an ultra-performance liquid chromatography-mass spectrometry (UPLC-MS) based metabolomic approach for the pharmacodynamic study of traditional Chinese medicines (TCMs)","volume":"13","author":"Wang","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.phcgj.2013.05.001","article-title":"Triterpenoid saponins from Lysimachia candida Lindl","volume":"5","author":"Xia","year":"2013","journal-title":"Pharmacognosy J."},{"key":"B34","doi-asserted-by":"publisher","first-page":"88","DOI":"10.4103\/2225-4110.110411","article-title":"Recent advances in the herbal treatment of non-alcoholic Fatty liver disease","volume":"3","author":"Xiao","year":"2013","journal-title":"J. Traditional Complement. Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/7498508","article-title":"8-Hydroxyeicosapentaenoic acid decreases plasma and hepatic triglycerides via activation of peroxisome proliferator-activated receptor alpha in high-fat diet-induced obese mice","volume":"2016","author":"Yamada","year":"2016","journal-title":"J. Lipids"},{"key":"B36","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1194\/jlr.M047514","article-title":"Hydroxyeicosapentaenoic acids from the Pacific krill show high ligand activities for PPARs","volume":"55","author":"Yamada","year":"2014","journal-title":"J. lipid Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"434","DOI":"10.6165\/tai.2012.57.434","article-title":". Lysimachia candida Lindl.(Primulaceae), extinct Species also a New Rec. Species Taiwan","volume":"57","author":"Yang","year":"2012","journal-title":"Taiwania"},{"key":"B38","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/nprot.2012.024","article-title":"A positive\/negative ion-switching, targeted mass spectrometry-based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue","volume":"7","author":"Yuan","year":"2012","journal-title":"Nat. Protoc."},{"key":"B39","doi-asserted-by":"publisher","first-page":"112034","DOI":"10.1016\/j.jep.2019.112034","article-title":"An herbal-compound-based combination therapy that relieves cirrhotic ascites by affecting the L-arginine\/nitric oxide pathway: A metabolomics-based systematic study","volume":"241","author":"Zhang","year":"2019","journal-title":"J. Ethnopharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.653872\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T20:19:17Z","timestamp":1618517957000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.653872\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,15]]},"references-count":39,"alternative-id":["10.3389\/fphar.2021.653872"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2021.653872","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,15]]},"article-number":"653872"}}